News
Researchers flag new cancer therapy that guards p53
Scientists in Scotland say that they have identified a chemical group that can protect the p53 gene, a guardian against cancer tumors which is damaged or turned off in most cancer cases. They believe Read more...
Fat cell research points to new approach on obesity
Swedish researchers have concluded that the number of fat cells present in the body is a constant, remaining unchanged regardless of how much a person weighs or gains. Every year about 10 percent of Read more...
Scientists forecasts use of stem cells to grow parts
UK cell biologist Robert Edwards says he can see a time in the not-too-distant future when humans will be able to grow new body parts through the use of stem cell technology. And the doctor, Read more...
ALSO NOTED: StemCyte to open NJ facility; Cornell researchers win million-dollar grant;
Stem Cell Research California's StemCyte will open a facility in New Jersey and hire 12 people to do stem cell research work. The company was drawn to the state with $589,000 in state grants. Read more...
Chance discovery links ACE inhibitors to weight loss
Australian scientists say that targeting angiotensin converting enzyme (ACE) can be an effective way to spur weight loss and prevent diabetes. And the research demonstrates that ACE-inhibitors could Read more...
Consortium uses 'virtual patients' to find drugs
Pfizer is providing $14.4 million to fund a research consortium involving four universities and Entelos, a company that does computer modeling for drug research work, in a drive to create a new class Read more...
Gene therapy helps improve sight of the blind
Two new human trials of a gene therapy for inherited blindness have demonstrated that injecting replacement genes under the retinas of the blind can spur at least partial sight in some volunteers. In Read more...
Counterpoint: An argument for industry-backed research
Management consultant Dr. David A. Shaywitz has joined with Dr. Dennis A. Ausiello, the physician-in-chief of Massachusetts General Hospital and a director at Pfizer, to deliver a rebuttal to a small Read more...
ALSO NOTED: Genetic mutation explains beta blocker failure; CytImmune lauded for nanotech research;New adult stem cell center;
Research Technology An article in the Journal of Alzheimer's Disease presents a detailed characterization of a new drug discovery tool for Alzheimer's disease. It demonstrates that an abnormal form Read more...
Biotechs use nanotech in pursuit of $100 sequencing bill
The bill on sequencing a genome has fallen from a few billion dollars to about $60,000 in just five years. And with most of the sequencing tech companies racing to be able to do it for Read more...
CRO worries grow as research business booms
By one estimate, CROs will see their contract research operations swell from $7 billion in 2006 to $19 billion in 2013 as more and more biotech companies turn to them to manage drug trials. But as Read more...
DelBello draws added scrutiny for undisclosed funds
University of Cincinnati researcher Melissa DelBello is getting some added scrutiny after finding herself Read more...
Merck KGaA budgets $1.58B for drug R&D
With about 40 drug development projects in the pipeline, Germany's Merck KGaA says it will spend about €1 billion ($1.58 billion) on drug research this year. That R&D budget represents Read more...
U.S. hatches $265M regenerative medicine initiative
The U.S. government is creating a $265 million research initiative that will develop new stem cell technology to re-grow the skin, limbs and muscles of soldiers injured in Iraq and Afghanistan. And Read more...
ALSO NOTED: Stem cells can treat irregular heartbeats; Gene removal reverses angiogenesis;Research points to powerful impact of
Stem Cell Research Researchers have found that adding stem cells with pacemaker genes into heart cells grown in a dish can create a regular beating pattern--an approach that may one day offer a new Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight